PULMATRIX, INC. Equity Method Investment, Ownership Percentage
PULMATRIX, INC. (PULM) had Equity Method Investment, Ownership Percentage of 17.00% as of 2015-03-13, per its 10-K filed 2015-06-10.
Discontinued › Notes
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2015-06-10
- 2015-03-13: Equity Method Investment, Ownership Percentage 17.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2015-03-13 | 17.00% 10-K · filed 2015-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |